According to the Urology Care Foundation, Muscle Invasive Bladder Cancer (MIBC) is a cancer that spreads into the detrusor muscle of the bladder, which is a thick muscle deep in the bladder wall. The bladder wall has many layers, made up of different types of cells. This cancer is more likely to spread to other parts of the body and about 1 out of 4 people who get bladder cancer in the United States have the muscle-invasive kind.

The causes for developing muscle invasive bladder cancer involve tobacco or other cancer-causing agents such as an exposure of inappropriate radiation beams that are focused on the pelvis during chemotherapy. Most bladder cancers start in the urothelium or transitional epithelium, which is the inside lining of the bladder. Transitional cell carcinoma is cancer that forms in the cells of the urothelium. Bladder Cancer gets worse when it grows into or through other layers of the bladder wall. Over time, the Muscle Invasive Bladder Cancer may grow outside the bladder into tissues, spreading to lymph nodes, bones, lungs, or liver and other parts of the body.

 

 

 

 

 

 

 

 

 

1. As per an study conducted by W. Martin et al. titled “The global epidemiology of bladder Cancer: a joinpoint regression analysis of its incidence and mortality trends and projection” found that Bladder Cancer was the ninth most common malignancy worldwide, with 430,000 newly diagnosed cases in 2012. In Europe, a total of 118,000 new cases and 52,000 deaths were estimated in the same year.

 

2. J. Witjes et al. conducted a study titled “Guidelines on Muscle-invasive and Metastatic Bladder Cancer” and found that in a retrospective study of patients who had undergone radical cystectomy, women were more likely to be diagnosed with the primary muscle-invasive disease than men (85% vs. 51%)

 

 

 

1. Musle Invasive Bladder Cancer market report covers a descriptive overview and comprehensive insight of the Musle Invasive Bladder Cancer Disease epidemiology Musle Invasive Bladder Cancer market in the 7MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Musle Invasive Bladder Cancer market report provides insights on the current and emerging therapies. 

3. Musle Invasive Bladder Cancer market report offers a global historical and forecasted market covering drug outreach in 7MM.

4. Musle Invasive Bladder Cancer market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Cold Agglutinin Disease market.

 

 

 

1. AstraZeneca

2. Merck Sharp & Dohme

 

1.  Durvalumab

 

 

1. Key Insights

2. Executive Summary of Muscle Invasive Bladder cancer

3. Competitive Intelligence Analysis for Muscle Invasive Bladder cancer

4. Muscle Invasive Bladder cancer: Market Overview at a Glanc

5. Muscle Invasive Bladder cancer: Disease Background and Overvie

6. Patient Journey

7. Muscle Invasive Bladder cancer Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices 

9. Unmet Needs

10. Key Endpoints of Muscle Invasive Bladder cancer Treatment

11. Marketed Products

12. Emerging Therapies

13. Muscle Invasive Bladder cancer: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Muscle Invasive Bladder cancer

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this Musle Invasive Bladder Cancer market report?

• The report will help in developing business strategies by understanding trends shaping and driving the Muscle Invasive Bladder cancer market
• To understand the future market competition in the Muscle Invasive Bladder cancer market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Muscle Invasive Bladder cancer in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Muscle Invasive Bladder cancer market
• To understand the future market competition in the Muscle Invasive Bladder cancer market

Related Reports:- 

1. Muscle Invasive Bladder cancer – Epidemiology Forecast to 2030